Healthcare, Life Sciences Leaders Expect M&A To Surge in 2026, Says KPMG
chiefhealthcareexecutive.com
|
Contributed by: Kate Gamble
Summary
A recent KPMG survey indicates that healthcare and life sciences leaders are optimistic about an increase in mergers and acquisitions by 2026, with 73% of life sciences executives and 61% of healthcare leaders planning to pursue more deals despite a challenging market. This optimism stands in contrast to a decline in expectations for valuation increases among these leaders, attributed to uncertainties in federal health policies and reimbursement rates. As hospitals and health systems navigate financial pressures, particularly with an anticipated rise in uninsured patients, they are shifting focus to investments in information technology and behavioral health. This trend highlights the ongoing transformation in the healthcare landscape, signaling potential implications for strategies in merger activities and technological investments.
